The Latest Cardiac and Vascular News
Clinical, science, and natural products industry experts to advance Company’s research, clinical studies, and product development strategies SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Calroy Health Sciences, a company dedicated to developing innovative natural solutions to optimize cardiovascular health, today announced the establishment of a science and medical advisory board comprised of leading researchers and […]
Results previously presented in a Late-Breaking Science Session at the American Heart Association’s 2021 Scientific Sessions Global Phase 3 trial of bentracimab achieved both primary reversal endpoint and co-primary endpoint of clinical hemostasis Bentracimab had no drug-related serious adverse events MALVERN, Pa. & SAN DIEGO–(BUSINESS WIRE)–PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a […]
This week on Investor Insights, host Ken Dropiewski interviews Justin Klein, MD, JD and Kirk Nielsen, both Co-Founders and Managing Partners of Vensana Capital. They discuss a number of topics including the future of MedTech, the changes within the industry over the last ten years, and the history of their […]
Seasoned electrophysiology sales executive joins the Company to expand the commercial footprint of its signal processing technology for arrhythmia care Westport, CT, Dec. 01, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve […]
The INSIGHT international, multicenter, randomized, placebo-controlled pivotal Phase II/III clinical study will be conducted with a 3.7 g/day dose of TOTUM•854 on 400 volunteers; The INSIGHT 2 international, multicenter, randomized, placebo-controlled Phase II/III clinical study will be conducted with a 2.6 g/day dose of TOTUM•854 on 400 volunteers; The clinical […]
Commence a strategic partnership to advance women’s heart and brain health through awareness and prevention TORONTO–(BUSINESS WIRE)–Munich Reinsurance Company’s Canadian life branch (Munich Re) today announced a strategic partnership with Heart & Stroke reinforcing its commitment to combatting cardiovascular disease. With this partnership, Munich Re will provide financial support for […]
PRAIRIE VILLAGE, Kan., Nov. 30, 2021 /PRNewswire/ — Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced that full results from its first-in-human (FIH) clinical study of the Amplifi™ Vein Dilation System were presented at the 2021 VEITH Symposium by Surendra Shenoy, MD-PhD, […]
Rouen, France, November 30, 2021 – Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, today announces the successful completion of the first coronary angioplasty in China assisted by its R-One™ robotic platform. The procedure took place at the 301 Hospital in Beijing on […]
First therapy to receive newly established French reimbursement designation VANCOUVER and MINNEAPOLIS, Nov. 30, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the Neovasc Reducer™ (“Reducer”) system has been granted Prise en Charge Transitoire (“PECT”) reimbursement in France by the national health authority, Haute Autorité de Santé (“HAS”). The decision […]
Eko donates smart stethoscope and telehealth kits to free & charitable clinics across 33 states, enhancing cardiac screening services to uninsured and medically underserved Americans OAKLAND, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) — Eko, a cardiopulmonary digital health company, today announced its partnership with the National Association of Free & Charitable Clinics (NAFC). […]
